The DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Review of the efficacy of nanoparticle-based drug delivery systems for cancer treatment
Open accessAbstract
This review evaluates the literature on nanoparticle-based drug delivery systems for cancer treatment and assesses their efficacy. Nanoparticles have shown potential for improving anticancer agent delivery, reducing systemic toxicity, and enhancing therapeutic outcomes. Extensive studies have shown promising results in preclinical and clinical trials. However, challenges such as limited drug loading capacity, stability issues, and potential side effects need to be addressed to enhance clinical translation. Researchers are exploring strategies to improve drug loading capacity, such as modifying nanoparticle surfaces or developing novel drug encapsulation techniques. By increasing drug loading, the therapeutic efficacy of these systems can be significantly enhanced. Stability issues also pose a hurdle in clinical translation. To overcome stability issues, researchers are investigating methods to enhance the stability of nanoparticles, such as using protective coatings or optimising the formulation. Additionally, efforts are being made to minimise potential side effects by carefully selecting biocompatible materials for nanoparticle synthesis and conducting rigorous toxicity studies before moving forward with clinical trials.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Aptamer-functionalized PEG–PLGA nanoparticles for enhanced anti-glioma drug delivery
Guo, J., Gao, X., Su, L., Xia, H., Gu, G., Pang, Z., Jiang, X., Yao, L., Chen, J., & Chen, H. (2011) · Biomaterials · doi:10.1016/j.biomaterials.2011.07.004 · Cited by 566
Polysaccharide-based nanoparticles for theranostic nanomedicine
Swierczewska, M., Han, H. S., Kim, K., Park, J. H., & Lee, S. (2016) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2015.11.015 · Cited by 415
Nanoparticle-based local antimicrobial drug delivery
Gao, W., Chen, Y., Zhang, Y., Zhang, Q., & Zhang, L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2017.09.015 · Cited by 396
Zhu, D., Tao, W., Zhang, H., Liu, G., Wang, T., Zhang, L., Zeng, X., & Mei, L. (2016) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.11.031 · Cited by 278
Microfluidics in nanoparticle drug delivery; From synthesis to pre-clinical screening
Ahn, J., Ko, J., Lee, S., Yu, J., Kim, Y., & Jeon, N. L. (2018) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2018.04.001 · Cited by 213
Magnetic Micro- and Nano-Particle-Based Targeting for Drug and Gene Delivery
Dobson, J. (2006) · Nanomedicine · doi:10.2217/17435889.1.1.31 · Cited by 195
Delivery of doxorubicin-loaded PLGA nanoparticles into U87 human glioblastoma cells
Malinovskaya, Y., Melnikov, P., Baklaushev, V., Gabashvili, A., Osipova, N., Mantrov, S., Ermolenko, Y., Maksimenko, O., Gorshkova, M., Balabanyan, V., et al. (2017) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2017.03.049 · Cited by 172
Functional chitosan oligosaccharide nanomicelles for topical ocular drug delivery of dexamethasone
Xu, X., Sun, L., Zhou, L., Cheng, Y., & Cao, F. (2020) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115356 · Cited by 153
Jin, M., Jin, G., Kang, L., Chen, L., Gao, Z., & Huang, W. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s161426 · Cited by 146
Advanced Therapeutic Strategies for Chronic Lung Disease Using Nanoparticle-Based Drug Delivery
Yhee, J. Y., Im, J., & Nho, R. S. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5090082 · Cited by 135
Qiu, F., Meng, T., Chen, Q., Zhou, K., Shao, Y. X., Greg, M. H., Ma, X., Wu, W., Du, Y., Wang, X., et al. (2019) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b01319 · Cited by 135
Virus-modified exosomes for targeted RNA delivery; A new approach in nanomedicine
Koppers‐Lalic, D., Hogenboom, M. M., Middeldorp, J. M., & Pegtel, D. M. (2012) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2012.07.006 · Cited by 132
Wang, G., & Uludağ, H. (2008) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.5.5.499 · Cited by 126
Targeted, Triggered Drug Delivery to Tumor and Biofilm Microenvironments
Benoit, D. S. W., & Koo, H. (2016) · Nanomedicine · doi:10.2217/nnm-2016-0014 · Cited by 126
Thermosensitive Polymeric Micelles for Targeted Drug Delivery
Talelli, M., & Hennink, W. E. (2011) · Nanomedicine · doi:10.2217/nnm.11.91 · Cited by 121
Production of nanoparticle drug delivery systems with microfluidics tools
Khan, I. U., Serra, C. A., Anton, N., & Vandamme, T. (2014) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2015.974547 · Cited by 119
RGD Peptide‐Based Target Drug Delivery of Doxorubicin Nanomedicine
Sun, Y., Chen, K., Liu, F., Zhou, Y., Luo, L., & Qiao, H. (2017) · Drug Development Research · doi:10.1002/ddr.21399 · Cited by 113
2D materials-based nanomedicine: From discovery to applications
Ouyang, J., Rao, S., Liu, R., Wang, L., Chen, W., Tao, W., & Kong, N. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114268 · Cited by 112
Nanostructured Porous Silicon–Polymer-Based Hybrids: From Biosensing to Drug Delivery
Bonanno, L. M., & Segal, E. (2011) · Nanomedicine · doi:10.2217/nnm.11.153 · Cited by 110
Insight on nano drug delivery systems with targeted therapy in treatment of oral cancer
Vyas, K., Rathod, M., & Patel, M. M. (2023) · Nanomedicine Nanotechnology Biology and Medicine · doi:10.1016/j.nano.2023.102662 · Cited by 108
Evolution of nanomedicine formulations for targeted delivery and controlled release
Puri, S., Mazza, M., Roy, G., England, R., Zhou, L., Nourian, S., & Subramony, J. A. (2023) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2023.114962 · Cited by 102
Cell membrane-derived Nanoparticles: Emerging Clinical Opportunities for Targeted Drug Delivery
Yurkin, S. T., & Wang, Z. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0100 · Cited by 100
Antitumoral activity of camptothecin-loaded nanoparticles in 9L rat glioma model
Çırpanlı, Y., Allard-Vannier, É., Passirani, C., Bilensoy, E., Lemaire, L. P., Çalış, S., & Benoît, J. (2010) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2010.10.015 · Cited by 99
Pan, Q., Xu, Q., Boylan, N. J., Lamb, N. W., Emmert, D. G., Yang, J., Tang, L. J., Heflin, T., Alwadani, S., Eberhart, C. G., et al. (2015) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.01.009 · Cited by 96
Hu, J., Fu, S., Peng, Q., Han, Y., Xie, J., Zan, N., Chen, Y., & Fan, J. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.11.047 · Cited by 90
Yu, Y., Chen, D., Li, Y., Yang, W., Tu, J., & Shen, Y. (2018) · Drug Delivery · doi:10.1080/10717544.2018.1458923 · Cited by 85
Nanoliposome-based antibacterial drug delivery
Hallaj‐Nezhadi, S., & Hassan, M. (2013) · Drug Delivery · doi:10.3109/10717544.2013.863409 · Cited by 81
PLGA Nanoparticles as Subconjunctival Injection for Management of Glaucoma
Ha, S., Ghorab, M. M., Mahmoud, A. A. K., & Hady, M. A. (2017) · AAPS PharmSciTech · doi:10.1208/s12249-017-0710-8 · Cited by 78
(2016) · Wiley eBooks · doi:10.1002/9781118833322 · Cited by 76
The role of imaging in targeted delivery of nanomedicine for cancer therapy
Li, P., Wang, D., Hu, J., & Yang, X. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114447 · Cited by 76
Patil, A., Lakhani, P. M., Taskar, P., Wu, K.-W., Sweeney, C., Avula, B., Wang, Y., Khan, I. A., & Majumdar, S. (2018) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2018.04.014 · Cited by 73
Careers in nanomedicine and drug delivery
Nance, E. A. (2019) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2019.06.009 · Cited by 68
Rodriguez-Aller, M., Guinchard, S., Guillarme, D., Pupier, M., Jeannerat, D., Rivara‐Minten, E., Veuthey, J., & Gurny, R. (2015) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2015.04.032 · Cited by 66
Liu, J., Zhang, X., Li, G., Xu, F., Li, S., Teng, L., Li, Y., & Sun, F. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s217038 · Cited by 65
Nanoparticle-based drug delivery systems to overcome gastric cancer drug resistance
Nejati‐Koshki, K., Rastegar, M., Fathi, F., Dadashpour, M., & Arabzadeh, A. (2022) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2022.103231 · Cited by 65
Wang, L., & Jia, E. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1101792 · Cited by 63
Hekmatara, T., Bernreuther, C., Khalansky, A. S., Theisen, A., Weissenberger, J., Matschke, J., Gelperina, S. E., Kreuter, J., & Glatzel, M. (2009) · Clinical Neuropathology · doi:10.5414/npp28153 · Cited by 61
Deep-Learning Models for Lipid Nanoparticle-Based Drug Delivery
Harrison, P. J., Wieslander, H., Sabirsh, A., Karlsson, J., Malmsjö, V., Hellander, A., Wählby, C., & Spjuth, O. (2021) · Nanomedicine · doi:10.2217/nnm-2020-0461 · Cited by 61
Nuclear Delivery of Nanoparticle-Based Drug Delivery Systems by Nuclear Localization Signals
Nie, Y., Fu, G., & Leng, Y. (2023) · Cells · doi:10.3390/cells12121637 · Cited by 61
Hirani, A., Grover, A., Lee, Y. W., Pathak, Y. V., & Sutariya, V. B. (2014) · Pharmaceutical Development and Technology · doi:10.3109/10837450.2014.965326 · Cited by 60
Nanomedicine-based delivery strategies for nucleic acid gene inhibitors in inflammatory diseases
Fattal, E., & Fay, F. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.05.019 · Cited by 60
Cyclodextrin–Amphiphilic Copolymer Supramolecular Assemblies for the Ocular Delivery of Natamycin
Lorenzo-Veiga, B., Sigurðsson, H. H., Loftsson, Þ., & Alvarez‐Lorenzo, C. (2019) · Nanomaterials · doi:10.3390/nano9050745 · Cited by 56
Hanafy, A. F., Abdalla, A. M., Guda, T. K., Gabr, K. E., Royall, P. G., & Alqurshi, A. A. (2019) · International Journal of Nanomedicine · doi:10.2147/ijn.s195892 · Cited by 55
Saux, S. L., Aubert‐Pouëssel, A., Mohamed, K. E., Martineau, P., Guglielmi, L., Devoisselle, J., Legrand, P., Chopineau, J., & Morille, M. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.113837 · Cited by 53
Chen, Z., Lai, X., Song, S., Zhu, X., & Zhu, J. (2015) · Drug Delivery · doi:10.3109/10717544.2015.1038857 · Cited by 49
Perlecan-Targeted Nanoparticles for Drug Delivery to Triple-Negative Breast Cancer
Khanna, V., Kalscheuer, S., Kirtane, A. R., Zhang, W., & Panyam, J. (2019) · Future Drug Discovery · doi:10.4155/fdd-2019-0005 · Cited by 49
Polyhydroxyalkanoate‐based drug delivery systems
Michalak, M., Kurcok, P., & Hakkarainen, M. (2016) · Polymer International · doi:10.1002/pi.5282 · Cited by 48
Small Angle X-Ray Scattering Technique for the Particle Size Distribution of Nonporous Nanoparticles
Agbabiaka, A., Wiltfong, M., & Park, C. (2013) · Journal of Nanoparticles · doi:10.1155/2013/640436 · Cited by 47
Clinical translational barriers against nanoparticle-based imaging agents
Jin, R., Fu, X., Pu, Y., Fu, S., Liang, H., Yang, L., Nie, Y., & Ai, H. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114587 · Cited by 46
Nanomedicine to Overcome Antimicrobial Resistance: Challenges and Prospects
Zou, W., McAdorey, A., Yan, H., & Chen, W. (2023) · Nanomedicine · doi:10.2217/nnm-2023-0022 · Cited by 46
Nanoparticle delivery and particle diffusion in confined and complex environments
Al-Obaidi, H., & Florence, A. T. (2015) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2015.06.017 · Cited by 45
Nanoparticle-based drug delivery for the treatment of traumatic brain injury
Mohammed, F. S., Omay, S. B., Sheth, K. N., & Zhou, J. (2022) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2023.2152001 · Cited by 44
A novel nanoparticle drug delivery system based on PEGylated hemoglobin for cancer therapy
Zhao, Y., Chen, G., Meng, Z., Gong, G., Zhao, W., Wang, K., & Liu, T. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1639846 · Cited by 40
Nanomedicine-based approaches for improved delivery of phyto-therapeutics for cancer therapy
Hafez, D. A., Elkhodairy, K. A., Teleb, M., & Elzoghby, A. O. (2020) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1723542 · Cited by 40
Zorzi, G. K., Schuh, R. S., Maschio, V. J., Brazil, N. T., Rott, M. B., & Teixeira, H. F. (2018) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2018.10.044 · Cited by 39
Jansook, P., Kulsirachote, P., Asasutjarit, R., & Loftsson, Þ. (2019) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2019.115209 · Cited by 39
Li, Y., Deng, G.-X., Hu, X., Li, C., Wang, X., Zhu, Q., Zheng, K., Xiong, W., & Wu, H. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0023 · Cited by 37
The Role of Nanomedicine in The Imaging and Therapy of Thrombosis
McCarthy, J. R., & Jaffer, F. A. (2011) · Nanomedicine · doi:10.2217/nnm.11.128 · Cited by 33
Preparation and study of two kinds of ophthalmic nano-preparations of everolimus
Tang, Z., Yin, L., Zhang, Y., Yu, W.-Y., Wang, Q., & Zhan, Z. (2019) · Drug Delivery · doi:10.1080/10717544.2019.1692966 · Cited by 32
Zhao, Y., Cai, C., Liu, M., Zhao, Y., Pei, W., Chu, X., Zhang, H., Wang, Z., & Han, J. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110394 · Cited by 31
Yang, C., & Merlin, D. (2019) · Expert Opinion on Drug Delivery · doi:10.1080/17425247.2020.1698543 · Cited by 31
Golla, K., Reddy, P. S., Bhaskar, C., & Kondapi, A. K. (2013) · Drug Delivery · doi:10.3109/10717544.2013.801051 · Cited by 29
New Strategies in Melanoma Therapy: Can Nanoparticles Overcome Chemoresistance?
Badea, I. (2017) · Nanomedicine · doi:10.2217/nnm-2017-0145 · Cited by 25
Huang, J., Yu, X., Zhou, Y., Zhang, R., Song, Q., Wang, Q., & Li, X. (2018) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2018.09.015 · Cited by 25
Akhtar, B., Muhammad, F., Aslam, B., Saleemi, M. K., & Sharif, A. (2020) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2020.101680 · Cited by 24
Recent Advances in Treatment of Lung Cancer: Nanoparticle-based Drug and siRNA Delivery Systems
Gencer, A., Duraloglu, C., Ozbay, S., Çiftçi, T., Ciftci, S. Y., & Arıca, B. (2020) · Current Drug Delivery · doi:10.2174/1567201817999200730211718 · Cited by 24
Bal‐Öztürk, A., Domingo, S., Yücel, O., Erol, T., Akgüner, Z. P., Darıcı, H., Alarçın, E., & Emik, S. (2023) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2023.104195 · Cited by 24
Garcia, C. R., Rad, A. T., Saeedinejad, F., Manojkumar, A., Roy, D., Rodrigo, H., Chew, S. A., Rahman, Z., Nieh, M., & Roy, U. (2022) · Nanomedicine · doi:10.2217/nnm-2022-0043 · Cited by 21
Targeted Bioadhesive Nanomedicine: An Effective Approach for Synergistic Drug Delivery to Cancers
Viswanadh, M. K., & Muthu, M. S. (2018) · Nanomedicine · doi:10.2217/nnm-2018-0114 · Cited by 20
Nanoscale Metal Particles as Nanocarriers in Targeted Drug Delivery System
Trigueros, S. (2016) · Journal of Nanomedicine Research · doi:10.15406/jnmr.2016.04.00086 · Cited by 19
Nanotoxicology and Challenges of Translation
PourGashtasbi, G. (2015) · Nanomedicine · doi:10.2217/nnm.15.131 · Cited by 14
Rajeeva, B. B., Menz, R., & Zheng, Y. (2014) · Nanomedicine · doi:10.2217/nnm.14.103 · Cited by 14
Iron oxide-doped niosomes as drug carriers for magnetically targeted drug delivery
Juneja, R., & Roy, I. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s125007 · Cited by 14
Editorial: Nanomedicine-Based Drug Delivery Systems: Recent Developments and Future Prospects
Shakeel, F. (2023) · Molecules · doi:10.3390/molecules28104138 · Cited by 14
Piret, G., & Prinz, C. N. (2016) · Nanomedicine · doi:10.2217/nnm.16.23 · Cited by 11
Exploring Novel Strategies for Lipid-Based Drug Delivery
Kotta, S., Sharma, N., Raturi, P., Aleem, M., & Sharma, R. K. (2018) · Journal of Nanotoxicology and Nanomedicine · doi:10.4018/jnn.2018010101 · Cited by 9
The Significance of Nanomedicine in Brain-Targeted Drug Delivery: Crossing Blood-Brain Barriers
Singh, D. (2017) · Journal of Nanomedicine Research · doi:10.15406/jnmr.2017.05.00132 · Cited by 7
Baiee, R. M., Liu, Z., & Li, L. (2018) · International Journal of Nanoparticles and Nanotechnology · doi:10.35840/2631-5084/5518 · Cited by 5
Benefits of Branched Polymeric Nanoparticles for Enhanced Targeted Drug Delivery
Doleyres, Y. (2020) · Nanomedicine & Nanotechnology Open Access · doi:10.23880/nnoa-16000187 · Cited by 4
Cited by
Nanoparticles in cancer theragnostic and drug delivery: A comprehensive review
Al-Thani, A. N., Jan, A. G., Abbas, M., Geetha, M., & Sadasivuni, K. K. (2024) · Life Sciences · doi:10.1016/j.lfs.2024.122899 · Cited by 323
Desai, N., Rana, D., Patel, M., Bajwa, N., Prasad, R., & Vora, L. K. (2025) · Small · doi:10.1002/smll.202502315 · Cited by 295
PEGylated PLGA nanoparticles: unlocking advanced strategies for cancer therapy
Kesharwani, P., Kumar, V., Goh, K. W., Gupta, G., Alsayari, A., Wahab, S., & Sahebkar, A. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02410-x · Cited by 132
Targeting Cellular Senescence for Healthy Aging: Advances in Senolytics and Senomorphics
Alum, E., Izah, S., Uti, D., Ugwu, O., Betiang, P., Basajja, M., & Ejemot-Nwadiaro, R. (2025) · Drug Design, Development and Therapy · doi:10.2147/dddt.s543211 · Cited by 63
Advances in 2,3-Dimethylmaleic Anhydride (DMMA)-Modified Nanocarriers in Drug Delivery Systems
Wan, D., Wu, Y., Liu, Y., Liu, Y., & Pan, J. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16060809 · Cited by 7
Metadata
- Authors
- Elumalai, K., Srinivasan, S., & Shanmugam, A.
- Venue
- Biomedical Technology
- Publisher
- Elsevier BV
- Published
- 2024-03
- Volume
- 5
- Pages
- 109-122
- ISSN
- 2949-723X (ISSN-L)
- OpenAlex
- W4387204689
- Cited by
- 649
- References
- 79
- FWCI
- 35.73
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.